Beauty Cosmetics Claiming Cannabis & CBD Ingredients: ROC FDA Regulatory Guidelines and Consumer Warnings

In recent years, skincare and cosmetic products claiming to contain cannabis extracts, hemp seed oil, and cannabidiol (CBD) have surged in popularity across North American and European beauty markets, frequently touting anti-inflammatory, soothing, and anti-aging benefits.

In response to international marketing trends, the Food and Drug Administration of the Ministry of Health and Welfare, Republic of China (ROC FDA) issued a public statement clarifying domestic regulatory boundaries to safeguard consumer health and ensure commercial compliance.

Regulatory Standpoint of the ROC FDA

Under current regulations in the Republic of China:

1. Tetrahydrocannabinol (THC) Restrictions: THC is classified as a Category 2 controlled narcotic. Any cosmetic formulation containing THC exceeding 10 ppm (0.001%) is strictly illegal under the Narcotics Hazard Prevention Act.
2. Hemp Seed Oil (Cannabis Sativa Seed Oil): Cold-pressed hemp seed oil derived from sterilized seeds is permitted in cosmetics provided it is thoroughly purified and free of psychoactive THC contamination.
3. Cannabidiol (CBD): While pure CBD is not categorized as a controlled narcotic, its medicinal properties require strict pharmaceutical evaluation. Cosmetic products formulated with CBD are currently not approved for commercial manufacture or unauthorized importation without specific regulatory licensing.

Consumer Advice

Consumers purchasing skincare products online or through overseas personal shoppers should exercise extreme caution. Importing unapproved cosmetics containing regulated cannabis constituents can result in confiscation at customs, administrative penalties, or potential criminal liability under narcotics control legislation. Always verify product ingredients through official authorized channels.